Geode Capital Management’s Indaptus Therapeutics INDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $169K | Buy |
56,470
+29,463
| +109% | +$74.2K | ﹤0.01% | 3970 |
|
|
2026
Q1 | $49.2K | Buy |
+27,007
| New | +$57.9K | ﹤0.01% | 4317 |
|
|
2025
Q2 | – | Sell |
-4,463
| Closed | -$68.7K | – | 4483 |
|
|
2025
Q1 | $68.7K | Buy |
4,463
+1,530
| +52% | +$35.3K | ﹤0.01% | 4126 |
|
|
2024
Q4 | $69.2K | Buy |
2,933
+321
| +12% | +$10.2K | ﹤0.01% | 4185 |
|
|
2024
Q3 | $90.7K | Buy |
2,612
+494
| +23% | +$24.2K | ﹤0.01% | 4133 |
|
|
2024
Q2 | $126K | Buy |
2,118
+162
| +8% | +$10.8K | ﹤0.01% | 4070 |
|
|
2024
Q1 | $123K | Hold |
1,956
| – | – | ﹤0.01% | 4099 |
|
|
2023
Q4 | $97K | Hold |
1,956
| – | – | ﹤0.01% | 4195 |
|
|
2023
Q3 | $149K | Buy |
1,956
+152
| +8% | +$10.3K | ﹤0.01% | 4099 |
|
|
2023
Q2 | $92.5K | Hold |
1,804
| – | – | ﹤0.01% | 4363 |
|
|
2023
Q1 | $93.5K | Hold |
1,804
| – | – | ﹤0.01% | 4363 |
|
|
2022
Q4 | $72K | Sell |
1,804
-4
| -0.2% | -$202 | ﹤0.01% | 4498 |
|
|
2022
Q3 | $109K | Sell |
1,808
-66
| -4% | -$5.14K | ﹤0.01% | 4538 |
|
|
2022
Q2 | $136K | Sell |
1,874
-2,163
| -54% | -$169K | ﹤0.01% | 4454 |
|
|
2022
Q1 | $452K | Buy |
4,037
+969
| +32% | +$124K | ﹤0.01% | 3983 |
|
|
2021
Q4 | $489K | Buy |
3,068
+2,088
| +213% | +$388K | ﹤0.01% | 4061 |
|
|
2021
Q3 | $214K | Buy |
+980
| New | +$283K | ﹤0.01% | 4420 |
|
|
2021
Q2 | – | Sell |
-135
| Closed | -$65K | – | 4729 |
|
|
2021
Q1 | $65K | Hold |
135
| – | – | ﹤0.01% | 4372 |
|
|
2020
Q4 | $52K | Buy |
135
+123
| +1,025% | +$53.7K | ﹤0.01% | 4162 |
|
|
2020
Q3 | $6K | Hold |
12
| – | – | ﹤0.01% | 4153 |
|
|
2020
Q2 | $7K | Hold |
12
| – | – | ﹤0.01% | 4096 |
|
|
2020
Q1 | $5K | Hold |
12
| – | – | ﹤0.01% | 4099 |
|
|
2019
Q4 | $13K | Hold |
12
| – | – | ﹤0.01% | 4181 |
|
|
2019
Q3 | $19K | Hold |
12
| – | – | ﹤0.01% | 4149 |
|
|
2019
Q2 | $117K | Buy |
12
+4
| +50% | +$50.5K | ﹤0.01% | 3922 |
|
|
2019
Q1 | $127K | Hold |
8
| – | – | ﹤0.01% | 3844 |
|
|
2018
Q4 | $130K | Hold |
8
| – | – | ﹤0.01% | 3810 |
|
|
2018
Q3 | $97K | Buy |
8
+2
| +33% | +$19K | ﹤0.01% | 3934 |
|
|
2018
Q2 | $55K | Buy |
+6
| New | +$66.5K | ﹤0.01% | 3966 |
|
Other funds holding INDP
HF
SS
Geode Capital Management's INDP Position: Q2 2026 in Review
Geode Capital Management increased its Indaptus Therapeutics (INDP) stake by 109% in Q2 2026, buying an estimated $74.2K and bringing the position to 56,470 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #3970.
Geode Capital Management first reported a position in INDP in Q2 2018 and has held it in 29 quarters since. The position peaked at $489K in Q4 2021. 9 funds tracked by Wall St. Rank hold INDP as of Q2 2026.
- Geode Capital Management held 56,470 shares of Indaptus Therapeutics worth $169K as of Q2 2026.
- Geode Capital Management bought 29,463 Indaptus Therapeutics shares in Q2 2026, an estimated $74.2K.
- Indaptus Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3970 holding.
- Geode Capital Management first reported a position in Indaptus Therapeutics in Q2 2018 and has held it in 29 quarters since.
- Geode Capital Management's Indaptus Therapeutics position peaked at $489K in Q4 2021.
- 9 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.